Abstract: The invention regards a method and system for recording observation data without violating privacy. Environment is sensed and observation data including information on the sensed environment is generated. The observation data is processed for determining presence of one or more persons in the sensed environment. Those person(s) amongst the present person(s) that did not agree to store their private data are identified and privacy compliant observation data is generated by obfuscating the private data of these persons. The privacy compliant observation data is store for later use.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

Abstract: An optical fiber for transmitting laser beams includes at least one fiber core, at least one fiber jacket, a sheath encompassing the fiber jacket, an interlayer between the fiber jacket and the sheath, in which the refractive index of the interlayer is lower than a refractive index of the corresponding fiber jacket that is in contact with the interlayer, and an outputting means for outputting leakage radiation from the fiber.

Abstract: A system includes sending of requests to a computing system based on a first number of users associated with a load test, evaluation of one or more characteristics of the computing system while sending the requests, determination to modify the first number of users to a second number of users based on the one or more evaluated characteristics, and sending of requests to the computing system based on the second number of users.

Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising N,N-diethyl-3-methylbenzamide as a solvent and an improved method for controlling, and preventing parasite infestation in animals.

Abstract: In summary, an optical transportation fiber (10) for transmitting laser beams (S0) comprises at least one fiber core (1), at least one fiber jacket (2, 3) and one sheath (5) encompassing the fiber jacket (2, 3), wherein an interlayer (4), the refraction index of which is lower than a refraction index of the corresponding fiber jacket (2, 3) being in contact with the interlayer (4), is provided between the fiber jacket (2, 3) and the sheath (5). Thereby, the fiber (10) is formed with at least one outputting means (11).

Abstract: A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Abstract: A method for operating an output stage for a piezoactuator includes checking, during an operating phase, in response to the undershooting of a current for the piezoactuator below a setpoint current, whether a point in time for the undershooting lies outside or within a time window. A subsequent current pulse is controlled via the setpoint current if the point in time is located outside the time window, and the subsequent current pulse is controlled via a turn-on time if the point in time is located within the time window.

Abstract: This invention provides topical localized formulations comprising an isoxazoline compound and a pharmaceutically or veterinary acceptable liquid carrier vehicle comprising glycofurol and an improved method for controlling, and preventing parasite infestation in animals.

Abstract: An IR radiant heater has at least one planar carbon heating element (1) arranged in a housing, which is transparent or at least partially transparent to IR radiation. At least one carbon heating element (1) is a carbon fiber-reinforced carbon (CFC) web arranged in a plane and arranged between two plates (2, 3), of which at least one is transparent or partially transparent.